2022
DOI: 10.3390/cimb44080243
|View full text |Cite
|
Sign up to set email alerts
|

1-L Transcription in Alzheimer’s Disease

Abstract: Alzheimer’s disease is a very complex disease and better explanations and models are needed to understand how neurons are affected and microglia are activated. A new model of Alzheimer’s disease is presented here, the β-amyloid peptide is considered an important RNA recognition/binding peptide. 1-L transcription revealed compatible sequences with AAUAAA (PAS signal) and UUUC (class III ARE rich in U) in the Aβ peptide, supporting the peptide–RNA regulatory model. When a hypothetical model of fibril selection w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 119 publications
0
1
0
Order By: Relevance
“…These changes can significantly influence the neuronal environment and potentially affect the progression of neurodegenerative diseases like AD. Given that VAV3 influences the release of cytokines and other signaling molecules from astrocytes, it is also plausible that VAV3 indirectly affects the inflammatory and immune responses in the AD brain, potentially modulating the formation and clearance of Aβ plaques 116 .…”
Section: Vav3mentioning
confidence: 99%
“…These changes can significantly influence the neuronal environment and potentially affect the progression of neurodegenerative diseases like AD. Given that VAV3 influences the release of cytokines and other signaling molecules from astrocytes, it is also plausible that VAV3 indirectly affects the inflammatory and immune responses in the AD brain, potentially modulating the formation and clearance of Aβ plaques 116 .…”
Section: Vav3mentioning
confidence: 99%
“…1-L transcription is a very simple method that was introduced recently [10, [13][14][15] and which applies a theoretical protein-RNA recognition code (Figure 1B) [16]. As shown in the figure for ribosomal release factor 1 (RF1) and tRNA, the primary protein structures are involved in protein-RNA recognition/interaction processes.…”
Section: Introductionmentioning
confidence: 99%
“…IBs, or physiologically aggregated peptides/proteins, which arise from mistranslation or other errors in translational and post-translational processes, are generally considered to be harmful in the elderly, and are mainly involved in neurodegenerative diseases [ 21 ]. For example, aggregation of β-amyloid peptide is mainly responsible for Alzheimer’s disease, while aggregation of α-synuclein is responsible for Parkinson’s disease and other synucleinopathies [ 21 , 22 , 23 ]. Oral administration of the diglucose derivative trehalose (Treh) reduces neurodegeneration and improves motor and cognitive performance in mouse models, albeit at a high concentration [ 24 , 25 ].…”
Section: Introductionmentioning
confidence: 99%